enGene Holdings Statistics

Total Valuation

enGene Holdings has a market cap or net worth of $228.38 million. The enterprise value is $39.70 million.

Market Cap	228.38M
Enterprise Value	39.70M

Important Dates

The last earnings date was Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

enGene Holdings has 50.98 million shares outstanding. The number of shares has increased by 606.66% in one year.

Current Share Class	n/a
Shares Outstanding	50.98M
Shares Change (YoY)	+606.66%
Shares Change (QoQ)	+14.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	24.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.91
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.16, with a Debt / Equity ratio of 0.10.

Current Ratio	17.16
Quick Ratio	16.54
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.16

Financial Efficiency

Return on equity (ROE) is -44.21% and return on invested capital (ROIC) is -26.98%.

Return on Equity (ROE)	-44.21%
Return on Assets (ROA)	-25.75%
Return on Invested Capital (ROIC)	-26.98%
Return on Capital Employed (ROCE)	-28.62%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, enGene Holdings has paid $29,000 in taxes.

Income Tax	29,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.65% in the last 52 weeks. The beta is -0.61, so enGene Holdings's price volatility has been lower than the market average.

Beta (5Y)	-0.61
52-Week Price Change	-88.65%
50-Day Moving Average	0.80
200-Day Moving Average	1.20
Relative Strength Index (RSI)	38.65
Average Volume (20 Days)	6,358

Short Selling Information

Short Interest	2
Short Previous Month	160
Short % of Shares Out	n/a
Short % of Float	0.00%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-78.14M
Pretax Income	n/a
Net Income	-69.05M
EBITDA	-78.02M
EBIT	-78.14M
Earnings Per Share (EPS)	-$1.54

Full Income Statement

Balance Sheet

The company has $213.81 million in cash and $25.13 million in debt, giving a net cash position of $188.68 million or $3.70 per share.

Cash & Cash Equivalents	213.81M
Total Debt	25.13M
Net Cash	188.68M
Net Cash Per Share	$3.70
Equity (Book Value)	249.95M
Book Value Per Share	4.90
Working Capital	209.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$66.61 million and capital expenditures -$718,000, giving a free cash flow of -$67.33 million.

Operating Cash Flow	-66.61M
Capital Expenditures	-718,000
Free Cash Flow	-67.33M
FCF Per Share	-$1.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

enGene Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-606.66%
Shareholder Yield	n/a
Earnings Yield	-30.23%
FCF Yield	-29.48%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3